These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8253998)

  • 1. Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.
    Biedenbach DJ; Jones RN; Erwin ME
    J Clin Microbiol; 1993 Oct; 31(10):2828-30. PubMed ID: 8253998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A; Jungwirth R
    Infection; 1991; 19(5):353-62. PubMed ID: 1800377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
    Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
    Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
    Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.
    Fung-Tomc JC; Huczko E; Stickle T; Minassian B; Kolek B; Denbleyker K; Bonner D; Kessler R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):533-8. PubMed ID: 7726528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
    Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
    Bale MJ; Jones RN
    J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of eight oral cephalosporins against Borrelia burgdorferi.
    Hunfeld KP; Rödel R; Wichelhaus TA
    Int J Antimicrob Agents; 2003 Apr; 21(4):313-8. PubMed ID: 12672576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
    Westblom TU; Gudipati S; Midkiff BR
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):691-3. PubMed ID: 2226500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards.
    Kibsey PC; Rennie RP; Rushton JE
    J Clin Microbiol; 1994 Nov; 32(11):2786-90. PubMed ID: 7852573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
    Knothe H; Shah PM; Eckardt O
    Infection; 1991; 19(5):370-6. PubMed ID: 1800379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
    Kleinkauf N; Rodloff AC
    Clin Microbiol Infect; 2001 Jun; 7(6):326-30. PubMed ID: 11442566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
    Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.